APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug-coated Balloon (DCB)

A drug-coated balloon (DCB) is an angioplasty balloon catheter in which an antiproliferative drug is coated onto the balloon surface and delivered to the vessel wall during transient balloon inflation, providing a localized therapeutic effect while leaving no permanent implant behind. The coating is engineered to remain stable on the balloon during tracking and deployment, then rapidly transfer an effective dose into the arterial tissue upon inflation, with the drug retained in the vessel wall to suppress neointimal hyperplasia and reduce restenosis after percutaneous transluminal angioplasty. In clinical use, DCB technology is applied across coronary and peripheral interventions, including femoropopliteal and below-the-knee vessels and selected dialysis-access lesions, and its performance is defined by the balance between deliverability, tissue drug transfer efficiency, and the control of downstream loss of coating material during the procedure.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A drug-coated balloon (DCB) is an angioplasty balloon catheter in which an antiproliferative drug is coated onto the balloon surface and delivered to the vessel wall during transient balloon inflation, providing a localized therapeutic effect while leaving no permanent implant behind. The coating is engineered to remain stable on the balloon during tracking and deployment, then rapidly transfer an effective dose into the arterial tissue upon inflation, with the drug retained in the vessel wall to suppress neointimal hyperplasia and reduce restenosis after percutaneous transluminal angioplasty. In clinical use, DCB technology is applied across coronary and peripheral interventions, including femoropopliteal and below-the-knee vessels and selected dialysis-access lesions, and its performance is defined by the balance between deliverability, tissue drug transfer efficiency, and the control of downstream loss of coating material during the procedure.

Selected research

Industry Growth & Trends

Global Drug-coated Balloon (DCB) Industry Growth and Trends Forecast to 2032

3 August 2026112 pages

Choose your research edition.

Industry ResearchDrug-coated Balloon (DCB) Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug-coated Balloon (DCB) Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Drug-coated Balloon (DCB) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug-coated Balloon (DCB) Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug-coated Balloon (DCB) Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

A drug-coated balloon (DCB) is an angioplasty balloon catheter in which an antiproliferative drug is coated onto the balloon surface and delivered to the vessel wall during transient balloon inflation, providing a localized therapeutic effect while leaving no permanent implant behind. The coating is engineered to remain stable on the balloon during tracking and deployment, then rapidly transfer an effective dose into the arterial tissue upon inflation, with the drug retained in the vessel wall to suppress neointimal hyperplasia and reduce restenosis after percutaneous transluminal angioplasty. In clinical use, DCB technology is applied across coronary and peripheral interventions, including femoropopliteal and below-the-knee vessels and selected dialysis-access lesions, and its performance is defined by the balance between deliverability, tissue drug transfer efficiency, and the control of downstream loss of coating material during the procedure.

The global Drug-coated Balloon (DCB) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Drug-coated Balloon (DCB) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

Read the full market overview

The Europe market for Drug-coated Balloon (DCB) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

The Asia Pacific market for Drug-coated Balloon (DCB) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Drug-coated Balloon (DCB) include Medtronic, Boston Scientific, Becton Dickinson, Biotronik, B. Braun, Philips, Abbott, Eurocor and Yinyi Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Drug-coated Balloon (DCB) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Drug-coated Balloon (DCB) market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Drug-coated Balloon (DCB) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Drug-coated Balloon (DCB).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Drug-coated Balloon (DCB) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Drug-coated Balloon (DCB) Market by Company

Medtronic

Boston Scientific

Becton Dickinson

Biotronik

B. Braun

Philips

Abbott

Eurocor

Yinyi Biotech

Lepu Medical

Grand Pharma

Acotec Scientific

Shenqi Medical

MicroPort

Zylox-Tonbridge Medical

Zhejiang Barty Medical

Drug-coated Balloon (DCB) Segment by Type

Coronary DCB

Peripheral DCB (FP)

Peripheral DCB (BTK)

Drug-coated Balloon (DCB) Segment by Application

Dialysis Access (AVF/AVG)

Femoropopliteal (FP)

Below-the-Knee (BTK)

Drug-coated Balloon (DCB) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug-coated Balloon (DCB) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug-coated Balloon (DCB) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug-coated Balloon (DCB).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Drug-coated Balloon (DCB) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Drug-coated Balloon (DCB) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Coronary DCB Table 2. Major Company of Peripheral DCB (FP) Table 3. Major Company of Peripheral DCB (BTK) Table 4. Global Drug-coated Balloon (DCB) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Drug-coated Balloon (DCB) Sales by Type (2021-2026) & (k units) Table 6. Global Drug-coated Balloon (DCB) Sales Market Share in Volume by Type (2021-2026) Table 7. Global Drug-coated Balloon (DCB) Sales by Type (2021-2026) & (US$ Million) Table 8. Global Drug-coated Balloon (DCB) Sales Market Share in Value by Type (2021-2026) Table 9. Global Drug-coated Balloon (DCB) Price by Type (2021-2026) & (USD/unit) Table 10. Global Drug-coated Balloon (DCB) Sales by Type (2027-2032) & (k units) Table 11. Global Drug-coated Balloon (DCB) Sales Market Share in Volume by Type (2027-2032) Table 12. Global Drug-coated Balloon (DCB) Sales by Type (2027-2032) & (US$ Million) Table 13. Global Drug-coated Balloon (DCB) Sales Market Share in Value by Type (2027-2032) Table 14. Global Drug-coated Balloon (DCB) Price by Type (2027-2032) & (USD/unit) Table 15. North America Drug-coated Balloon (DCB) Sales by Type (2021-2026) & (k units) Table 16. North America Drug-coated Balloon (DCB) Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Drug-coated Balloon (DCB) Sales by Type (2021-2026) & (k units) Table 18. Europe Drug-coated Balloon (DCB) Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Drug-coated Balloon (DCB) Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Drug-coated Balloon (DCB) Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Drug-coated Balloon (DCB) Sales by Type (2021-2026) & (k units) Table 22. Latin America Drug-coated Balloon (DCB) Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Drug-coated Balloon (DCB) Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Drug-coated Balloon (DCB) Sales by Type (2021-2026) & (US$ Million) Table 25. Drug-coated Balloon (DCB) Industry Trends Table 26. Drug-coated Balloon (DCB) Industry Drivers Table 27. Drug-coated Balloon (DCB) Industry Opportunities and Challenges Table 28. Drug-coated Balloon (DCB) Industry Restraints Table 29. Global Drug-coated Balloon (DCB) Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Drug-coated Balloon (DCB) Revenue Market Share by Company (2021-2026) Table 31. Global Drug-coated Balloon (DCB) Sales by Company (2021-2026) & (k units) Table 32. Global Drug-coated Balloon (DCB) Sales Share by Company (2021-2026) Table 33. Global Drug-coated Balloon (DCB) Market Price by Company (2021-2026) & (USD/unit) Table 34. Global Drug-coated Balloon (DCB) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Drug-coated Balloon (DCB) Major Company Production Sites and Headquarters Table 36. Global Drug-coated Balloon (DCB) Company, Product Type & Application Table 37. Global Drug-coated Balloon (DCB) Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Drug-coated Balloon (DCB) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Drug-coated Balloon (DCB) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Drug-coated Balloon (DCB) Sales by Region (2021-2026) & (k units) Table 42. Global Drug-coated Balloon (DCB) Sales Market Share in Volume by Region (2021-2026) Table 43. Global Drug-coated Balloon (DCB) Sales by Region (2021-2026) & (US$ Million) Table 44. Global Drug-coated Balloon (DCB) Sales Market Share in Value by Region (2021-2026) Table 45. Global Drug-coated Balloon (DCB) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Global Drug-coated Balloon (DCB) Sales by Region (2027-2032) & (k units) Table 47. Global Drug-coated Balloon (DCB) Sales Market Share in Volume by Region (2027-2032) Table 48. Global Drug-coated Balloon (DCB) Sales by Region (2027-2032) & (US$ Million) Table 49. Global Drug-coated Balloon (DCB) Sales Market Share in Value by Region (2027-2032) Table 50. Global Drug-coated Balloon (DCB) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 51. Global Drug-coated Balloon (DCB) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Drug-coated Balloon (DCB) Sales by Application (2021-2026) & (k units) Table 53. Global Drug-coated Balloon (DCB) Sales Market Share in Volume by Application (2021-2026) Table 54. Global Drug-coated Balloon (DCB) Sales by Application (2021-2026) & (US$ Million) Table 55. Global Drug-coated Balloon (DCB) Sales Market Share in Value by Application (2021-2026) Table 56. Global Drug-coated Balloon (DCB) Price by Application (2021-2026) & (USD/unit) Table 57. Global Drug-coated Balloon (DCB) Sales by Application (2027-2032) & (k units) Table 58. Global Drug-coated Balloon (DCB) Sales Market Share in Volume by Application (2027-2032) Table 59. Global Drug-coated Balloon (DCB) Sales by Application (2027-2032) & (US$ Million) Table 60. Global Drug-coated Balloon (DCB) Sales Market Share in Value by Application (2027-2032) Table 61. Global Drug-coated Balloon (DCB) Price by Application (2027-2032) & (USD/unit) Table 62. North America Drug-coated Balloon (DCB) Sales by Application (2021-2026) & (k units) Table 63. North America Drug-coated Balloon (DCB) Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Drug-coated Balloon (DCB) Sales by Application (2021-2026) & (k units) Table 65. Europe Drug-coated Balloon (DCB) Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Drug-coated Balloon (DCB) Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Drug-coated Balloon (DCB) Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Drug-coated Balloon (DCB) Sales by Application (2021-2026) & (k units) Table 69. Latin America Drug-coated Balloon (DCB) Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Drug-coated Balloon (DCB) Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Drug-coated Balloon (DCB) Sales by Application (2021-2026) & (US$ Million) Table 72. Medtronic Company Information Table 73. Medtronic Business Overview Table 74. Medtronic Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. Medtronic Drug-coated Balloon (DCB) Product Portfolio Table 76. Medtronic Recent Development Table 77. Boston Scientific Company Information Table 78. Boston Scientific Business Overview Table 79. Boston Scientific Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. Boston Scientific Drug-coated Balloon (DCB) Product Portfolio Table 81. Boston Scientific Recent Development Table 82. Becton Dickinson Company Information Table 83. Becton Dickinson Business Overview Table 84. Becton Dickinson Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. Becton Dickinson Drug-coated Balloon (DCB) Product Portfolio Table 86. Becton Dickinson Recent Development Table 87. Biotronik Company Information Table 88. Biotronik Business Overview Table 89. Biotronik Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Biotronik Drug-coated Balloon (DCB) Product Portfolio Table 91. Biotronik Recent Development Table 92. B. Braun Company Information Table 93. B. Braun Business Overview Table 94. B. Braun Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. B. Braun Drug-coated Balloon (DCB) Product Portfolio Table 96. B. Braun Recent Development Table 97. Philips Company Information Table 98. Philips Business Overview Table 99. Philips Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Philips Drug-coated Balloon (DCB) Product Portfolio Table 101. Philips Recent Development Table 102. Abbott Company Information Table 103. Abbott Business Overview Table 104. Abbott Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Abbott Drug-coated Balloon (DCB) Product Portfolio Table 106. Abbott Recent Development Table 107. Eurocor Company Information Table 108. Eurocor Business Overview Table 109. Eurocor Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Eurocor Drug-coated Balloon (DCB) Product Portfolio Table 111. Eurocor Recent Development Table 112. Yinyi Biotech Company Information Table 113. Yinyi Biotech Business Overview Table 114. Yinyi Biotech Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Yinyi Biotech Drug-coated Balloon (DCB) Product Portfolio Table 116. Yinyi Biotech Recent Development Table 117. Lepu Medical Company Information Table 118. Lepu Medical Business Overview Table 119. Lepu Medical Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Lepu Medical Drug-coated Balloon (DCB) Product Portfolio Table 121. Lepu Medical Recent Development Table 122. Grand Pharma Company Information Table 123. Grand Pharma Business Overview Table 124. Grand Pharma Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Grand Pharma Drug-coated Balloon (DCB) Product Portfolio Table 126. Grand Pharma Recent Development Table 127. Acotec Scientific Company Information Table 128. Acotec Scientific Business Overview Table 129. Acotec Scientific Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Acotec Scientific Drug-coated Balloon (DCB) Product Portfolio Table 131. Acotec Scientific Recent Development Table 132. Shenqi Medical Company Information Table 133. Shenqi Medical Business Overview Table 134. Shenqi Medical Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Shenqi Medical Drug-coated Balloon (DCB) Product Portfolio Table 136. Shenqi Medical Recent Development Table 137. MicroPort Company Information Table 138. MicroPort Business Overview Table 139. MicroPort Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. MicroPort Drug-coated Balloon (DCB) Product Portfolio Table 141. MicroPort Recent Development Table 142. Zylox-Tonbridge Medical Company Information Table 143. Zylox-Tonbridge Medical Business Overview Table 144. Zylox-Tonbridge Medical Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. Zylox-Tonbridge Medical Drug-coated Balloon (DCB) Product Portfolio Table 146. Zylox-Tonbridge Medical Recent Development Table 147. Zhejiang Barty Medical Company Information Table 148. Zhejiang Barty Medical Business Overview Table 149. Zhejiang Barty Medical Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. Zhejiang Barty Medical Drug-coated Balloon (DCB) Product Portfolio Table 151. Zhejiang Barty Medical Recent Development Table 152. North America Drug-coated Balloon (DCB) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 153. North America Drug-coated Balloon (DCB) Sales by Country (2021-2026) & (k units) Table 154. North America Drug-coated Balloon (DCB) Sales Market Share by Country (2021-2026) Table 155. North America Drug-coated Balloon (DCB) Sales Forecast by Country (2027-2032) & (k units) Table 156. North America Drug-coated Balloon (DCB) Sales Market Share Forecast by Country (2027-2032) Table 157. North America Drug-coated Balloon (DCB) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. North America Drug-coated Balloon (DCB) Market Size by Country (2021-2026) & (US$ Million) Table 159. North America Drug-coated Balloon (DCB) Market Share by Country (2021-2026) Table 160. North America Drug-coated Balloon (DCB) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. North America Drug-coated Balloon (DCB) Market Share Forecast by Country (2027-2032) Table 162. Europe Drug-coated Balloon (DCB) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 163. Europe Drug-coated Balloon (DCB) Sales by Country (2021-2026) & (k units) Table 164. Europe Drug-coated Balloon (DCB) Sales Market Share by Country (2021-2026) Table 165. Europe Drug-coated Balloon (DCB) Sales Forecast by Country (2027-2032) & (k units) Table 166. Europe Drug-coated Balloon (DCB) Sales Market Share Forecast by Country (2027-2032) Table 167. Europe Drug-coated Balloon (DCB) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Europe Drug-coated Balloon (DCB) Market Size by Country (2021-2026) & (US$ Million) Table 169. Europe Drug-coated Balloon (DCB) Market Share by Country (2021-2026) Table 170. Europe Drug-coated Balloon (DCB) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Europe Drug-coated Balloon (DCB) Market Share Forecast by Country (2027-2032) Table 172. Asia-Pacific Drug-coated Balloon (DCB) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 173. Asia-Pacific Drug-coated Balloon (DCB) Sales by Country (2021-2026) & (k units) Table 174. Asia-Pacific Drug-coated Balloon (DCB) Sales Market Share by Country (2021-2026) Table 175. Asia-Pacific Drug-coated Balloon (DCB) Sales Forecast by Country (2027-2032) & (k units) Table 176. Asia-Pacific Drug-coated Balloon (DCB) Sales Market Share Forecast by Country (2027-2032) Table 177. Asia-Pacific Drug-coated Balloon (DCB) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Asia-Pacific Drug-coated Balloon (DCB) Market Size by Country (2021-2026) & (US$ Million) Table 179. Asia-Pacific Drug-coated Balloon (DCB) Market Share by Country (2021-2026) Table 180. Asia-Pacific Drug-coated Balloon (DCB) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Asia-Pacific Drug-coated Balloon (DCB) Market Share Forecast by Country (2027-2032) Table 182. Latin America Drug-coated Balloon (DCB) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 183. Latin America Drug-coated Balloon (DCB) Sales by Country (2021-2026) & (k units) Table 184. Latin America Drug-coated Balloon (DCB) Sales Market Share by Country (2021-2026) Table 185. Latin America Drug-coated Balloon (DCB) Sales Forecast by Country (2027-2032) & (k units) Table 186. Latin America Drug-coated Balloon (DCB) Sales Market Share Forecast by Country (2027-2032) Table 187. Latin America Drug-coated Balloon (DCB) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Latin America Drug-coated Balloon (DCB) Market Size by Country (2021-2026) & (US$ Million) Table 189. Latin America Drug-coated Balloon (DCB) Market Share by Country (2021-2026) Table 190. Latin America Drug-coated Balloon (DCB) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Latin America Drug-coated Balloon (DCB) Market Share Forecast by Country (2027-2032) Table 192. Middle East and Africa Drug-coated Balloon (DCB) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 193. Middle East and Africa Drug-coated Balloon (DCB) Sales by Country (2021-2026) & (k units) Table 194. Middle East and Africa Drug-coated Balloon (DCB) Sales Market Share by Country (2021-2026) Table 195. Middle East and Africa Drug-coated Balloon (DCB) Sales Forecast by Country (2027-2032) & (k units) Table 196. Middle East and Africa Drug-coated Balloon (DCB) Sales Market Share Forecast by Country (2027-2032) Table 197. Middle East and Africa Drug-coated Balloon (DCB) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 198. Middle East and Africa Drug-coated Balloon (DCB) Market Size by Country (2021-2026) & (US$ Million) Table 199. Middle East and Africa Drug-coated Balloon (DCB) Market Share by Country (2021-2026) Table 200. Middle East and Africa Drug-coated Balloon (DCB) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 201. Middle East and Africa Drug-coated Balloon (DCB) Market Share Forecast by Country (2027-2032) Table 202. Key Raw Materials Table 203. Raw Materials Key Suppliers Table 204. Drug-coated Balloon (DCB) Distributors List Table 205. Drug-coated Balloon (DCB) Customers List Table 206. Research Programs/Design for This Report Table 207. Authors List of This Report Table 208. Secondary Sources Table 209. Primary Sources List of Figures Figure 1. Drug-coated Balloon (DCB) Image Figure 2. Global Drug-coated Balloon (DCB) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug-coated Balloon (DCB) Market Size (2021-2032) & (US$ Million) Figure 4. Global Drug-coated Balloon (DCB) Sales (2021-2032) & (k units) Figure 5. Coronary DCB Image Figure 6. Global Coronary DCB Sales YoY Growth (2021-2032) & (k units) Figure 7. Peripheral DCB (FP) Image Figure 8. Global Peripheral DCB (FP) Sales YoY Growth (2021-2032) & (k units) Figure 9. Peripheral DCB (BTK) Image Figure 10. Global Peripheral DCB (BTK) Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Drug-coated Balloon (DCB) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Drug-coated Balloon (DCB) Market Share by Type 2025 VS 2032 Figure 13. North America Drug-coated Balloon (DCB) Sales Market Share in Volume by Type in 2025 Figure 14. North America Drug-coated Balloon (DCB) Sales Market Share in Value by Type in 2025 Figure 15. Europe Drug-coated Balloon (DCB) Sales Market Share in Volume by Type in 2025 Figure 16. Europe Drug-coated Balloon (DCB) Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Drug-coated Balloon (DCB) Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Drug-coated Balloon (DCB) Sales Market Share in Value by Type in 2025 Figure 19. Latin America Drug-coated Balloon (DCB) Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Drug-coated Balloon (DCB) Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Drug-coated Balloon (DCB) Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Drug-coated Balloon (DCB) Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Drug-coated Balloon (DCB) Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Dialysis Access (AVF/AVG) Image Figure 26. Global Dialysis Access (AVF/AVG) Sales YoY Growth (2021-2032) & (k units) Figure 27. Femoropopliteal (FP) Image Figure 28. Global Femoropopliteal (FP) Sales YoY Growth (2021-2032) & (k units) Figure 29. Below-the-Knee (BTK) Image Figure 30. Global Below-the-Knee (BTK) Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Drug-coated Balloon (DCB) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Drug-coated Balloon (DCB) Market Share by Application 2025 VS 2032 Figure 33. North America Drug-coated Balloon (DCB) Sales Market Share in Volume by Application in 2025 Figure 34. North America Drug-coated Balloon (DCB) Sales Market Share in Value by Application in 2025 Figure 35. Europe Drug-coated Balloon (DCB) Sales Market Share in Volume by Application in 2025 Figure 36. Europe Drug-coated Balloon (DCB) Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Drug-coated Balloon (DCB) Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Drug-coated Balloon (DCB) Sales Market Share in Value by Application in 2025 Figure 39. Latin America Drug-coated Balloon (DCB) Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Drug-coated Balloon (DCB) Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Drug-coated Balloon (DCB) Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Drug-coated Balloon (DCB) Sales Market Share in Value by Application in 2025 Figure 43. North America Drug-coated Balloon (DCB) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Drug-coated Balloon (DCB) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Drug-coated Balloon (DCB) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Drug-coated Balloon (DCB) Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Drug-coated Balloon (DCB) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Drug-coated Balloon (DCB) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Drug-coated Balloon (DCB) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Drug-coated Balloon (DCB) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Drug-coated Balloon (DCB) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Drug-coated Balloon (DCB) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Drug-coated Balloon (DCB) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Drug-coated Balloon (DCB) Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Drug-coated Balloon (DCB) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Drug-coated Balloon (DCB) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Drug-coated Balloon (DCB) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Drug-coated Balloon (DCB) Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Drug-coated Balloon (DCB) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Drug-coated Balloon (DCB) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Drug-coated Balloon (DCB) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Drug-coated Balloon (DCB) Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Drug-coated Balloon (DCB) Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Drug-coated Balloon (DCB) Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Coronary DCB
  • Peripheral DCB (FP)
  • Peripheral DCB (BTK)
Applications
  • Dialysis Access (AVF/AVG)
  • Femoropopliteal (FP)
  • Below-the-Knee (BTK)
Companies covered
  • Medtronic
  • Boston Scientific
  • Becton Dickinson
  • Biotronik
  • B. Braun
  • Philips
  • Abbott
  • Eurocor
  • Yinyi Biotech
  • Lepu Medical
  • Grand Pharma
  • Acotec Scientific
  • Shenqi Medical
  • MicroPort
  • Zylox-Tonbridge Medical
  • Zhejiang Barty Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Drug-coated Balloon (DCB) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Drug-coated Balloon (DCB) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Drug-coated Balloon (DCB) Market by Type
  6. 1.3.1 Coronary DCB
  7. 1.3.2 Peripheral DCB (FP)
  8. 1.3.3 Peripheral DCB (BTK)
  9. 1.4 Global Drug-coated Balloon (DCB) Market Size by Type
  10. 1.4.1 Global Drug-coated Balloon (DCB) Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Drug-coated Balloon (DCB) Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Drug-coated Balloon (DCB) Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Drug-coated Balloon (DCB) Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Drug-coated Balloon (DCB) Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Drug-coated Balloon (DCB) Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Drug-coated Balloon (DCB) Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Drug-coated Balloon (DCB) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Drug-coated Balloon (DCB) Industry Trends
  2. 2.2 Drug-coated Balloon (DCB) Industry Drivers
  3. 2.3 Drug-coated Balloon (DCB) Industry Opportunities and Challenges
  4. 2.4 Drug-coated Balloon (DCB) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Drug-coated Balloon (DCB) Revenue (2021-2026)
  2. 3.2 Global Top Players by Drug-coated Balloon (DCB) Sales (2021-2026)
  3. 3.3 Global Top Players by Drug-coated Balloon (DCB) Price (2021-2026)
  4. 3.4 Global Drug-coated Balloon (DCB) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Drug-coated Balloon (DCB) Major Company Production Sites & Headquarters
  6. 3.6 Global Drug-coated Balloon (DCB) Company, Product Type & Application
  7. 3.7 Global Drug-coated Balloon (DCB) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Drug-coated Balloon (DCB) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Drug-coated Balloon (DCB) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Drug-coated Balloon (DCB) Tier 1, Tier 2, and Tier 3
4 Drug-coated Balloon (DCB) Regional Status and Outlook
  1. 4.1 Global Drug-coated Balloon (DCB) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Drug-coated Balloon (DCB) Historic Market Size by Region
  3. 4.2.1 Global Drug-coated Balloon (DCB) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Drug-coated Balloon (DCB) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Drug-coated Balloon (DCB) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Drug-coated Balloon (DCB) Forecasted Market Size by Region
  7. 4.3.1 Global Drug-coated Balloon (DCB) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Drug-coated Balloon (DCB) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Drug-coated Balloon (DCB) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Drug-coated Balloon (DCB) by Application
  1. 5.1 Drug-coated Balloon (DCB) Market by Application
  2. 5.1.1 Dialysis Access (AVF/AVG)
  3. 5.1.2 Femoropopliteal (FP)
  4. 5.1.3 Below-the-Knee (BTK)
  5. 5.2 Global Drug-coated Balloon (DCB) Market Size by Application
  6. 5.2.1 Global Drug-coated Balloon (DCB) Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Drug-coated Balloon (DCB) Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Drug-coated Balloon (DCB) Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Drug-coated Balloon (DCB) Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Drug-coated Balloon (DCB) Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Drug-coated Balloon (DCB) Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Drug-coated Balloon (DCB) Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Drug-coated Balloon (DCB) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Medtronic
  2. 6.1.1 Medtronic Company Information
  3. 6.1.2 Medtronic Business Overview
  4. 6.1.3 Medtronic Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Medtronic Drug-coated Balloon (DCB) Product Portfolio
  6. 6.1.5 Medtronic Recent Developments
  7. 6.2 Boston Scientific
  8. 6.2.1 Boston Scientific Company Information
  9. 6.2.2 Boston Scientific Business Overview
  10. 6.2.3 Boston Scientific Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Boston Scientific Drug-coated Balloon (DCB) Product Portfolio
  12. 6.2.5 Boston Scientific Recent Developments
  13. 6.3 Becton Dickinson
  14. 6.3.1 Becton Dickinson Company Information
  15. 6.3.2 Becton Dickinson Business Overview
  16. 6.3.3 Becton Dickinson Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Becton Dickinson Drug-coated Balloon (DCB) Product Portfolio
  18. 6.3.5 Becton Dickinson Recent Developments
  19. 6.4 Biotronik
  20. 6.4.1 Biotronik Company Information
  21. 6.4.2 Biotronik Business Overview
  22. 6.4.3 Biotronik Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Biotronik Drug-coated Balloon (DCB) Product Portfolio
  24. 6.4.5 Biotronik Recent Developments
  25. 6.5 B. Braun
  26. 6.5.1 B. Braun Company Information
  27. 6.5.2 B. Braun Business Overview
  28. 6.5.3 B. Braun Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 B. Braun Drug-coated Balloon (DCB) Product Portfolio
  30. 6.5.5 B. Braun Recent Developments
  31. 6.6 Philips
  32. 6.6.1 Philips Company Information
  33. 6.6.2 Philips Business Overview
  34. 6.6.3 Philips Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Philips Drug-coated Balloon (DCB) Product Portfolio
  36. 6.6.5 Philips Recent Developments
  37. 6.7 Abbott
  38. 6.7.1 Abbott Company Information
  39. 6.7.2 Abbott Business Overview
  40. 6.7.3 Abbott Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Abbott Drug-coated Balloon (DCB) Product Portfolio
  42. 6.7.5 Abbott Recent Developments
  43. 6.8 Eurocor
  44. 6.8.1 Eurocor Company Information
  45. 6.8.2 Eurocor Business Overview
  46. 6.8.3 Eurocor Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Eurocor Drug-coated Balloon (DCB) Product Portfolio
  48. 6.8.5 Eurocor Recent Developments
  49. 6.9 Yinyi Biotech
  50. 6.9.1 Yinyi Biotech Company Information
  51. 6.9.2 Yinyi Biotech Business Overview
  52. 6.9.3 Yinyi Biotech Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Yinyi Biotech Drug-coated Balloon (DCB) Product Portfolio
  54. 6.9.5 Yinyi Biotech Recent Developments
  55. 6.10 Lepu Medical
  56. 6.10.1 Lepu Medical Company Information
  57. 6.10.2 Lepu Medical Business Overview
  58. 6.10.3 Lepu Medical Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Lepu Medical Drug-coated Balloon (DCB) Product Portfolio
  60. 6.10.5 Lepu Medical Recent Developments
  61. 6.11 Grand Pharma
  62. 6.11.1 Grand Pharma Company Information
  63. 6.11.2 Grand Pharma Business Overview
  64. 6.11.3 Grand Pharma Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Grand Pharma Drug-coated Balloon (DCB) Product Portfolio
  66. 6.11.5 Grand Pharma Recent Developments
  67. 6.12 Acotec Scientific
  68. 6.12.1 Acotec Scientific Company Information
  69. 6.12.2 Acotec Scientific Business Overview
  70. 6.12.3 Acotec Scientific Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Acotec Scientific Drug-coated Balloon (DCB) Product Portfolio
  72. 6.12.5 Acotec Scientific Recent Developments
  73. 6.13 Shenqi Medical
  74. 6.13.1 Shenqi Medical Company Information
  75. 6.13.2 Shenqi Medical Business Overview
  76. 6.13.3 Shenqi Medical Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Shenqi Medical Drug-coated Balloon (DCB) Product Portfolio
  78. 6.13.5 Shenqi Medical Recent Developments
  79. 6.14 MicroPort
  80. 6.14.1 MicroPort Company Information
  81. 6.14.2 MicroPort Business Overview
  82. 6.14.3 MicroPort Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 MicroPort Drug-coated Balloon (DCB) Product Portfolio
  84. 6.14.5 MicroPort Recent Developments
  85. 6.15 Zylox-Tonbridge Medical
  86. 6.15.1 Zylox-Tonbridge Medical Company Information
  87. 6.15.2 Zylox-Tonbridge Medical Business Overview
  88. 6.15.3 Zylox-Tonbridge Medical Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Zylox-Tonbridge Medical Drug-coated Balloon (DCB) Product Portfolio
  90. 6.15.5 Zylox-Tonbridge Medical Recent Developments
  91. 6.16 Zhejiang Barty Medical
  92. 6.16.1 Zhejiang Barty Medical Company Information
  93. 6.16.2 Zhejiang Barty Medical Business Overview
  94. 6.16.3 Zhejiang Barty Medical Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Zhejiang Barty Medical Drug-coated Balloon (DCB) Product Portfolio
  96. 6.16.5 Zhejiang Barty Medical Recent Developments
7 North America by Country
  1. 7.1 North America Drug-coated Balloon (DCB) Sales by Country
  2. 7.1.1 North America Drug-coated Balloon (DCB) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Drug-coated Balloon (DCB) Sales by Country (2021-2026)
  4. 7.1.3 North America Drug-coated Balloon (DCB) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Drug-coated Balloon (DCB) Market Size by Country
  6. 7.2.1 North America Drug-coated Balloon (DCB) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Drug-coated Balloon (DCB) Market Size by Country (2021-2026)
  8. 7.2.3 North America Drug-coated Balloon (DCB) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Drug-coated Balloon (DCB) Sales by Country
  2. 8.1.1 Europe Drug-coated Balloon (DCB) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Drug-coated Balloon (DCB) Sales by Country (2021-2026)
  4. 8.1.3 Europe Drug-coated Balloon (DCB) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Drug-coated Balloon (DCB) Market Size by Country
  6. 8.2.1 Europe Drug-coated Balloon (DCB) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Drug-coated Balloon (DCB) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Drug-coated Balloon (DCB) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Drug-coated Balloon (DCB) Sales by Country
  2. 9.1.1 Asia-Pacific Drug-coated Balloon (DCB) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Drug-coated Balloon (DCB) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Drug-coated Balloon (DCB) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Drug-coated Balloon (DCB) Market Size by Country
  6. 9.2.1 Asia-Pacific Drug-coated Balloon (DCB) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Drug-coated Balloon (DCB) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Drug-coated Balloon (DCB) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Drug-coated Balloon (DCB) Sales by Country
  2. 10.1.1 South America Drug-coated Balloon (DCB) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Drug-coated Balloon (DCB) Sales by Country (2021-2026)
  4. 10.1.3 South America Drug-coated Balloon (DCB) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Drug-coated Balloon (DCB) Market Size by Country
  6. 10.2.1 South America Drug-coated Balloon (DCB) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Drug-coated Balloon (DCB) Market Size by Country (2021-2026)
  8. 10.2.3 South America Drug-coated Balloon (DCB) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Drug-coated Balloon (DCB) Sales by Country
  2. 11.1.1 Middle East and Africa Drug-coated Balloon (DCB) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Drug-coated Balloon (DCB) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Drug-coated Balloon (DCB) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Drug-coated Balloon (DCB) Market Size by Country
  6. 11.2.1 Middle East and Africa Drug-coated Balloon (DCB) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Drug-coated Balloon (DCB) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Drug-coated Balloon (DCB) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Drug-coated Balloon (DCB) Value Chain Analysis
  2. 12.1.1 Drug-coated Balloon (DCB) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Drug-coated Balloon (DCB) Production Mode & Process
  7. 12.2 Drug-coated Balloon (DCB) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Drug-coated Balloon (DCB) Distributors
  10. 12.2.3 Drug-coated Balloon (DCB) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst